Gamgee logo
StartupHealth & bio

Gamgee

Curing cancer. Starting with dogs.

Visit gamgee.ioSee on the map
About

​Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring ​We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

BiotechGenomicsOncologyAI
Facts
Website
gamgee.io
City
San Francisco
Country
United States
YC batch
Summer 2026
Team
2 people
Stage
Early stage
AI-native
Yes

See it on the San Francisco mapSource Spot something wrong?

More Health & bio in San Francisco

Is this your company?

Claim this profile

Free and instant: prove you run gamgee.io and edit the profile yourself.

  • Your logo, office address and founder photos
  • The ✓ Verified mark next to Gamgee across the site
  • Open roles listed on the Hiring board
  • A followed link back to your website
For your website

A rank card with Gamgee's standing on Labspie, or a simple badge. Both link to this profile and update themselves.

Gamgee is listed on Labspie